CN107802561A - One kind nursing eye gel and its production method - Google Patents
One kind nursing eye gel and its production method Download PDFInfo
- Publication number
- CN107802561A CN107802561A CN201711354382.8A CN201711354382A CN107802561A CN 107802561 A CN107802561 A CN 107802561A CN 201711354382 A CN201711354382 A CN 201711354382A CN 107802561 A CN107802561 A CN 107802561A
- Authority
- CN
- China
- Prior art keywords
- extract
- eye
- gel
- purified water
- acrylic copolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
The invention discloses one kind to nurse eye gel, include the component of following weight percent proportioning, acrylic copolymer, allantoin, propane diols, gaultherolin, camomile extract, lutein, moutan root bark extract, cassia seed extract, green-tea extract, hydrolyzed vegetable protein, tocopherol（Vitamin E）, niacinamide, menthol, Matrixyl 5, Sodium Hyaluronate, purified water；The invention also discloses the specific production method of nursing eye gel, the present invention can effectively alleviate kopiopia, eliminate livid ring around eye, eye circumference oedema, and crease-resistant, work of relaxing, and to pre- myopia prevention, recovering vision health, control and prevention eye illness illness etc. also has certain effect.
Description
Technical field
The present invention relates to a kind of gel for Nutritional Nursing Care eye, the specific production work of the nursing eye gel is further related to
Skill.
Background technology
With the quickening of modern cultural rhythm of life, work, learn overstretched, over-burden for psychological quality, gives birth in addition
The unclean pollution of state environment, such as dirt in air, the influence of smog air quality and itself stress, it is improper that work and rest is coordinated,
Long-term excess eye-using, stay up late, eyes sufficiently cannot be raised and rested, while the eyes lesion that factors induce is increasingly
More, different degrees of lesion can cause eye vision to decline, and form myopia, amblyopia, visual fatigue or aching and tired, eye frame pain of eye etc. occur
Disease.Most common is exactly livid ring around eye and eye circumference oedema.Proved by modern scientific research, the livid ring around eye and eye circumference occurred after staying up late
Oedema causes the result that local aqueous is detained and melanin deposition is formed mainly due to eye circumference microcirculation disorder, and eye is good for
Health and the outward appearance of people can all bring unfavorable factor.
Long-term livid ring around eye and eye circumference oedema are the performances of kopiopia, and it is usually associated with, and eye is dry, eye is puckery, eye is sour swollen, depending on thing
Fuzzy even visual impairment directly affects the work and life of people.The common eye drops for preventing kopiopia has pearl eyesight
Liquid, Naphazoline hydrochloride chterphenarmine maleate and vitamin eye drops, taurine etc., it is long-term use of easily to produce medicine although being had certain effect to alleviating kopiopia
Thing relies on, and is easy to trigger the problems such as locally or systemically physiological-toxicity is reacted, curative effect increasingly can also be led in unobvious, more serious meeting
The organic change of eyes is caused, produces serious consequence.
Therefore, develop a kind of effectively alleviation kopiopia, eliminate livid ring around eye, eye circumference oedema, and the crease-resistant, medicine living that relaxes is very
It is necessary.This is to eliminating visual fatigue, and pre- myopia prevention, recovering vision health, control and prevention eye illness illness etc. also has certain effect
Fruit.
The content of the invention
It is good that the technical problems to be solved by the invention are to provide a kind of using effect, can carry out nutritional supplementation to eye,
Anti-drying nursing eye gel.
In order to solve the above technical problems, the technical scheme is that：One kind nursing eye gel, including following weight hundred
The component of distribution ratio,
Acrylic copolymer 0.5~1.5, allantoin 0.6~1, propane diols 3~5, gaultherolin 0.5~1.5, chamomile carry
Take thing 0.5~1.5, lutein 0.1~0.3, moutan root bark extract 0.5~1.5, cassia seed extract 0.5~1.5, green tea
Extract 0.5~1.5, hydrolyzed vegetable protein 0.5~1.5, tocopherol（Vitamin E）0.5~1.5, niacinamide 0.3~0.7, thin
Lotus brain 0.3~0.7, Matrixyl -5 0.1~0.3, Sodium Hyaluronate 0.05~0.15, purified water 85~86.
As preferable technical scheme, include the component that following weight percent matches,
Acrylic copolymer 0.5, allantoin 0.6, propane diols 3, gaultherolin 0.5, camomile extract 0.5, lutein
0.1st, moutan root bark extract 0.5, cassia seed extract 0.5, green-tea extract 0.5, hydrolyzed vegetable protein 0.5, tocopherol（Dimension
Raw plain E）0.5th, niacinamide 0.3, menthol 0.3, Matrixyl -5 0.1, Sodium Hyaluronate 0.05, purified water 85.
As preferable technical scheme, include the component that following weight percent matches,
Acrylic copolymer 1, allantoin 0.8, propane diols 4, gaultherolin 1, camomile extract 1, lutein 0.2, tree peony
Root bark extract 1, cassia seed extract 1, green-tea extract 1, hydrolyzed vegetable protein 1, tocopherol（Vitamin E）1st, niacinamide
0.5th, menthol 0.5, Matrixyl -5 0.2, Sodium Hyaluronate 0.1, purified water 85.7.
As preferable technical scheme, include the component that following weight percent matches,
Acrylic copolymer 1.5, allantoin 1, propane diols 5, gaultherolin 1.5, camomile extract 1.5, lutein 0.3,
Moutan root bark extract 1.5, cassia seed extract 1.5, green-tea extract 1.5, hydrolyzed vegetable protein 1.5, tocopherol（Vitamin
E）1.5th, niacinamide 0.7, menthol 0.7, Matrixyl -5 0.3, Sodium Hyaluronate 0.15, purified water 86.
The invention also discloses the specific production method of above-mentioned nursing eye gel,
The each component of percentage by weight is taken, the purified water of at least 1 times amount is added into acrylic copolymer, makes acrylic copolymer
Dissolving, allantoin, propane diols are added into acrylic acid copolymer soln, and be well mixed, then add gaultherolin, chamomile
Extract, lutein, moutan root bark extract, cassia seed extract, green-tea extract, stir, and form gel-type vehicle；
Again by hydrolyzed vegetable protein, tocopherol（Vitamin E）, niacinamide, menthol, Matrixyl -5 and Sodium Hyaluronate according to
It is secondary to add in the gel-type vehicle formed, and surplus purified water is added, stirring, be put into turnover barrel, standing is no less than 24h,
Form nursing eye gel.
As the improvement to above-mentioned technical proposal, the nursing eye gel stood is sampled inspection, it is qualified to examine
Afterwards, filling, packaging is carried out again successively, finally by finished product detection warehousing after passing.
By adopting the above-described technical solution, the beneficial effects of the invention are as follows：Kopiopia can effectively be alleviated, eliminate black eye
Circle, eye circumference oedema, and crease-resistant, work of relaxing, to pre- myopia prevention, recovery vision health, control and prevention eye illness illness etc. also has certain
Effect.
Camomile extract can not only balanced fat secretion, press down fat anti-acne, prevent acne, eliminate blackspot, skin whitening, and
And there is suppression and bactericidal action to some skin pathogenicity fungies.Lutein is to retinal pigment degeneration, ARM and white
Cataract or glaucoma has obvious prevention and improvement, also with blood vessel dilatation function and strong oxidation resistance, can improve that eye is micro- to follow
Ring, improve eye nutrition supply, prevent oxidative damage of the free radical to eye.Moutan root bark extract has sterilizing work
With.Cassia seed extract energy heat-clearing improving eyesight.Green-tea extract has the effects such as anti-oxidant, removing free radical, while has recovery
With the effect of protection function of vascular endothelium.Hydrolyzed vegetable protein not only has abundant nutritive and health protection components, and with preferable
Flavor characteristic.Tocopherol（Vitamin E）High body immunity is resistant to, strengthens resistance against diseases, skin care, removes color spot, U.S.
Pale skin, spot can be made thin out.Blood vessel can also be protected.Niacinamide helps to maintain cell health.Menthol has the function that to refresh oneself.
Matrixyl -5 promotes to produce collagen, while protects collagen not decomposed by matrix metalloproteinase, and both cooperate with
Effect, effective eliminating wrinkle, improve skin quality.Sodium Hyaluronate can carry out reparation moisturizing to eye part skin.
Embodiment
With reference to embodiment, the present invention is expanded on further.In the following detailed description, only retouched by way of explanation
Some one exemplary embodiments of the present invention are stated.Undoubtedly, one of ordinary skill in the art will recognize, without departing from
In the case of the spirit and scope of the present invention, the described embodiments may be modified in various different ways.Therefore,
Description is inherently illustrative, is not intended to limit the scope of the claims.
Embodiment one：
One kind nursing eye gel, include the component of following weight percent proportioning,
Acrylic copolymer 0.5~1.5, allantoin 0.6~1, propane diols 3~5, gaultherolin 0.5~1.5, chamomile carry
Take thing 0.5~1.5, lutein 0.1~0.3, moutan root bark extract 0.5~1.5, cassia seed extract 0.5~1.5, green tea
Extract 0.5~1.5, hydrolyzed vegetable protein 0.5~1.5, tocopherol（Vitamin E）0.5~1.5, niacinamide 0.3~0.7, thin
Lotus brain 0.3~0.7, Matrixyl -5 0.1~0.3, Sodium Hyaluronate 0.05~0.15, purified water 85~86.
Specifically include the component of following weight percent proportioning, acrylic copolymer 0.5, allantoin 0.6, propane diols 3, bigcatkin willow
Sour methyl esters 0.5, camomile extract 0.5, lutein 0.1, moutan root bark extract 0.5, cassia seed extract 0.5, green tea carry
Take thing 0.5, hydrolyzed vegetable protein 0.5, tocopherol（Vitamin E）0.5th, niacinamide 0.3, menthol 0.3, Matrixyl -5
0.1st, Sodium Hyaluronate 0.05, purified water 85.
The specific production method of the present embodiment is：
The each component of percentage by weight is taken, the purified water of at least 1 times amount is added into acrylic copolymer, makes acrylic copolymer
Dissolving, allantoin, propane diols are added into acrylic acid copolymer soln, and be well mixed, then add gaultherolin, chamomile
Extract, lutein, moutan root bark extract, cassia seed extract, green-tea extract, stir, and form gel-type vehicle；
Again by hydrolyzed vegetable protein, tocopherol（Vitamin E）, niacinamide, menthol, Matrixyl -5 and Sodium Hyaluronate according to
It is secondary to add in the gel-type vehicle formed, and surplus purified water is added, stirring, be put into turnover barrel, standing is no less than 24h,
Form nursing eye gel.
For the ease of that using market demands, the nursing eye gel stood can be sampled to inspection, it is qualified to examine
Afterwards, filling, packaging is carried out again successively, finally by finished product detection warehousing after passing.
Embodiment two：
The present embodiment is that the degree of each component is different from the difference of embodiment one, and the present embodiment includes following weight hundred
The component of distribution ratio,
Acrylic copolymer 1, allantoin 0.8, propane diols 4, gaultherolin 1, camomile extract 1, lutein 0.2, tree peony
Root bark extract 1, cassia seed extract 1, green-tea extract 1, hydrolyzed vegetable protein 1, tocopherol（Vitamin E）1st, niacinamide
0.5th, menthol 0.5, Matrixyl -5 0.2, Sodium Hyaluronate 0.1, purified water 85.7.
Embodiment three：
The present embodiment is that the degree of each component is different from the difference of other embodiments, and the present embodiment includes following weight
The component of per distribution ratio,
Acrylic copolymer 1.5, allantoin 1, propane diols 5, gaultherolin 1.5, camomile extract 1.5, lutein 0.3,
Moutan root bark extract 1.5, cassia seed extract 1.5, green-tea extract 1.5, hydrolyzed vegetable protein 1.5, tocopherol（Vitamin
E）1.5th, niacinamide 0.7, menthol 0.7, Matrixyl -5 0.3, Sodium Hyaluronate 0.15, purified water 86.
Although embodiment two, embodiment three are different from each component weight percent proportioning of embodiment one, production method phase
Seemingly, production preparation can be carried out using the method that embodiment one illustrates.
By adopting the above-described technical solution, the beneficial effects of the invention are as follows：Kopiopia can effectively be alleviated, eliminate black eye
Circle, eye circumference oedema, and crease-resistant, work of relaxing, to pre- myopia prevention, recovery vision health, control and prevention eye illness illness etc. also has certain
Effect.
General principle, principal character and the advantages of the present invention of the present invention has been shown and described above.The technology of the industry
Personnel are it should be appreciated that the present invention is not limited to the above embodiments, and the simply explanation described in above-described embodiment and specification is originally
The principle of invention, without departing from the spirit and scope of the present invention, various changes and modifications of the present invention are possible, these changes
Change and improvement all fall within the protetion scope of the claimed invention.The claimed scope of the invention by appended claims and its
Equivalent thereof.
Claims (6)
1. one kind nursing eye gel, it is characterised in that：Include the component of following weight percent proportioning,
Acrylic copolymer 0.5~1.5, allantoin 0.6~1, propane diols 3~5, gaultherolin 0.5~1.5, chamomile carry
Take thing 0.5~1.5, lutein 0.1~0.3, moutan root bark extract 0.5~1.5, cassia seed extract 0.5~1.5, green tea
Extract 0.5~1.5, hydrolyzed vegetable protein 0.5~1.5, tocopherol（Vitamin E）0.5~1.5, niacinamide 0.3~0.7, thin
Lotus brain 0.3~0.7, Matrixyl -5 0.1~0.3, Sodium Hyaluronate 0.05~0.15, purified water 85~86.
A kind of 2. nursing eye gel as claimed in claim 1, it is characterised in that：Include the group of following weight percent proportioning
Point,
Acrylic copolymer 0.5, allantoin 0.6, propane diols 3, gaultherolin 0.5, camomile extract 0.5, lutein
0.1st, moutan root bark extract 0.5, cassia seed extract 0.5, green-tea extract 0.5, hydrolyzed vegetable protein 0.5, tocopherol（Dimension
Raw plain E）0.5th, niacinamide 0.3, menthol 0.3, Matrixyl -5 0.1, Sodium Hyaluronate 0.05, purified water 85.
A kind of 3. nursing eye gel as claimed in claim 1, it is characterised in that：Include the group of following weight percent proportioning
Point,
Acrylic copolymer 1, allantoin 0.8, propane diols 4, gaultherolin 1, camomile extract 1, lutein 0.2, tree peony
Root bark extract 1, cassia seed extract 1, green-tea extract 1, hydrolyzed vegetable protein 1, tocopherol（Vitamin E）1st, niacinamide
0.5th, menthol 0.5, Matrixyl -5 0.2, Sodium Hyaluronate 0.1, purified water 85.7.
A kind of 4. nursing eye gel as claimed in claim 1, it is characterised in that：Include the group of following weight percent proportioning
Point,
Acrylic copolymer 1.5, allantoin 1, propane diols 5, gaultherolin 1.5, camomile extract 1.5, lutein 0.3,
Moutan root bark extract 1.5, cassia seed extract 1.5, green-tea extract 1.5, hydrolyzed vegetable protein 1.5, tocopherol（Vitamin
E）1.5th, niacinamide 0.7, menthol 0.7, Matrixyl -5 0.3, Sodium Hyaluronate 0.15, purified water 86.
A kind of 5. production method of nursing eye gel as described in Claims 1-4 any claim, it is characterised in that：
The each component of percentage by weight is taken, the purified water of at least 1 times amount is added into acrylic copolymer, makes acrylic copolymer
Dissolving, allantoin, propane diols are added into acrylic acid copolymer soln, and be well mixed, then add gaultherolin, chamomile
Extract, lutein, moutan root bark extract, cassia seed extract, green-tea extract, stir, and form gel-type vehicle；
Again by hydrolyzed vegetable protein, tocopherol（Vitamin E）, niacinamide, menthol, Matrixyl -5 and Sodium Hyaluronate according to
It is secondary to add in the gel-type vehicle formed, and surplus purified water is added, stirring, be put into turnover barrel, standing is no less than 24h,
Form nursing eye gel.
A kind of 6. nursing eye gel as claimed in claim 5, it is characterised in that：The nursing eye gel stood is carried out
Inspection by sampling, after the assay was approved, filling, packaging is carried out again successively, finally by finished product detection warehousing after passing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711354382.8A CN107802561A (en) | 2017-12-15 | 2017-12-15 | One kind nursing eye gel and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711354382.8A CN107802561A (en) | 2017-12-15 | 2017-12-15 | One kind nursing eye gel and its production method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107802561A true CN107802561A (en) | 2018-03-16 |
Family
ID=61589256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711354382.8A Pending CN107802561A (en) | 2017-12-15 | 2017-12-15 | One kind nursing eye gel and its production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107802561A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109010375A (en) * | 2018-09-11 | 2018-12-18 | 厦门阿欧客健康科技有限公司 | A kind of collyrium |
| CN109288714A (en) * | 2018-11-21 | 2019-02-01 | 广州若双化妆品有限公司 | A kind of eye cream of blue ray radiation preventing and preparation method thereof |
| CN109394612A (en) * | 2018-11-15 | 2019-03-01 | 广州秉科医药科技有限公司 | Facial mask and preparation method thereof is repaired in a kind of moisturizing |
| CN109431836A (en) * | 2018-11-15 | 2019-03-08 | 广州博科健康科技集团有限公司 | One kind removing scar composition and preparation method thereof |
| CN110585133A (en) * | 2019-09-06 | 2019-12-20 | 舒仲秋 | Eye spray formula and preparation method |
| CN110787082A (en) * | 2019-09-29 | 2020-02-14 | 广州达达眼健康管理有限公司 | Eye cell repair composition and eye care product containing same |
| CN112190617A (en) * | 2020-10-20 | 2021-01-08 | 李恭瑞 | Nutrient solution for relieving eye fatigue and preparation method thereof |
| WO2021218107A1 (en) * | 2020-04-28 | 2021-11-04 | 苏州辑里丝绸有限公司 | Sleep mask for treating visual fatigue |
| CN113768965A (en) * | 2021-09-23 | 2021-12-10 | 重庆视健眼健康产业有限公司 | Borneol eye spray |
| US11571378B2 (en) | 2021-01-22 | 2023-02-07 | The Procter & Gamble Company | Skin care composition and method of using the same |
| US11771637B2 (en) | 2021-01-22 | 2023-10-03 | The Procter & Gamble Company | Skin care composition and method of using the same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05178763A (en) * | 1991-02-19 | 1993-07-20 | Nippon Saafuakutanto Kogyo Kk | Resolvent composition for sparingly soluble medicine |
| CN103655373A (en) * | 2013-12-23 | 2014-03-26 | 青岛安信医疗器械有限公司 | Eye mask |
| CN105640854A (en) * | 2016-01-08 | 2016-06-08 | 青岛康尔生物工程有限公司 | Roe and royal jelly tightening eye care gel and preparation method thereof |
-
2017
- 2017-12-15 CN CN201711354382.8A patent/CN107802561A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05178763A (en) * | 1991-02-19 | 1993-07-20 | Nippon Saafuakutanto Kogyo Kk | Resolvent composition for sparingly soluble medicine |
| CN103655373A (en) * | 2013-12-23 | 2014-03-26 | 青岛安信医疗器械有限公司 | Eye mask |
| CN105640854A (en) * | 2016-01-08 | 2016-06-08 | 青岛康尔生物工程有限公司 | Roe and royal jelly tightening eye care gel and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 沈晶晶等: "温度敏感型凝胶基质的研究进展", 《中国新药杂志》 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109010375A (en) * | 2018-09-11 | 2018-12-18 | 厦门阿欧客健康科技有限公司 | A kind of collyrium |
| CN109394612A (en) * | 2018-11-15 | 2019-03-01 | 广州秉科医药科技有限公司 | Facial mask and preparation method thereof is repaired in a kind of moisturizing |
| CN109431836A (en) * | 2018-11-15 | 2019-03-08 | 广州博科健康科技集团有限公司 | One kind removing scar composition and preparation method thereof |
| CN109288714A (en) * | 2018-11-21 | 2019-02-01 | 广州若双化妆品有限公司 | A kind of eye cream of blue ray radiation preventing and preparation method thereof |
| CN110585133A (en) * | 2019-09-06 | 2019-12-20 | 舒仲秋 | Eye spray formula and preparation method |
| CN110787082A (en) * | 2019-09-29 | 2020-02-14 | 广州达达眼健康管理有限公司 | Eye cell repair composition and eye care product containing same |
| WO2021218107A1 (en) * | 2020-04-28 | 2021-11-04 | 苏州辑里丝绸有限公司 | Sleep mask for treating visual fatigue |
| CN112190617A (en) * | 2020-10-20 | 2021-01-08 | 李恭瑞 | Nutrient solution for relieving eye fatigue and preparation method thereof |
| US11571378B2 (en) | 2021-01-22 | 2023-02-07 | The Procter & Gamble Company | Skin care composition and method of using the same |
| US11771637B2 (en) | 2021-01-22 | 2023-10-03 | The Procter & Gamble Company | Skin care composition and method of using the same |
| US11850299B2 (en) | 2021-01-22 | 2023-12-26 | The Procter & Gamble Company | Skin care composition and method of using the same |
| CN113768965A (en) * | 2021-09-23 | 2021-12-10 | 重庆视健眼健康产业有限公司 | Borneol eye spray |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107802561A (en) | One kind nursing eye gel and its production method | |
| CN109091675B (en) | Compound low-concentration atropine medicine eye drops and preparation method thereof | |
| CN106333885A (en) | Plant extract and eye essence liquid | |
| CN103860625A (en) | Cranberry extract eye ophthalmic preparation and preparation method and uses thereof | |
| CN107412258A (en) | It is a kind of that there is the health care eye sticker for alleviating visual fatigue function | |
| CN109805400A (en) | A kind of cowberry lutein health food for alleviating visual fatigue | |
| CN107343830A (en) | A kind of spontaneous heating medicine cover glass | |
| CN106620639A (en) | Lutein-containing compound plant eye mask with effect of supplementing eye nutrients to resist wrinkles | |
| CN109010375A (en) | A kind of collyrium | |
| CN107137599A (en) | A kind of anthocyanidin formula eye sticker and preparation method thereof | |
| CN106822233A (en) | Improve product of xerophthalmia and preparation method thereof | |
| CN101612161A (en) | A kind of eye medicine combination and preparation thereof | |
| CN101129698B (en) | Eye drops containing turmeric extractive and preparation method thereof | |
| CN109260136A (en) | A kind of eyeshield frost and preparation method thereof | |
| CN103933198A (en) | Active mineral ion eye drops | |
| CN104436156A (en) | Eyesight protective agent xanthophyll eye preparation and preparation process thereof | |
| CN111110817A (en) | Traditional Chinese medicine composition for treating eye diseases, preparation method and application thereof | |
| CN105309927A (en) | Compound healthcare product containing xanthophyll | |
| CN104824644A (en) | Food suitable for vision protection | |
| CN103550357B (en) | A kind of control muscae volitantes collyrium and its production and use | |
| CN106563122A (en) | Pure traditional Chinese medicine eye pad mainly used for treating true and pseudo myopia, and preparation method thereof | |
| CN104432087A (en) | Compound health product containing lutein | |
| CN104721233A (en) | Pharmaceutical preparation for treating heart diseases and cardiovascular diseases | |
| CN104905236A (en) | Formula of food-scale health product with effects of radiation damage prevention and repair and eyesight improving | |
| CN106074626A (en) | A kind of alleviate dry and astringent antibacterial liquid of eye and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180316 |
|
| WD01 | Invention patent application deemed withdrawn after publication |